Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Centocor files sBLA for infliximab in RA indication

Jan. 27, 1999

Cypress Bioscience to collaborate with Fresenius; FDA requests more information for Prosorba Column

Jan. 27, 1999

British Biotech continues search for MMP inhibitors

Jan. 25, 1999

Searle's celecoxib: the first COX-2 inhibitor reaches the market

Jan. 25, 1999

Celebrex approved in first market outside U.S.

Jan. 22, 1999

Snow Brand reports new developments concerning cevimeline

Jan. 22, 1999

Chugai presents new COX-2 inhibitor series

Jan. 22, 1999

Medarex and Centeon begin phase II study of MDX-33 as ITP treatment

Jan. 14, 1999

Medeva acquires license for scleroderma Rx from Connetics

Jan. 13, 1999

Priority review status granted for Merck & Co.'s COX-2 inhibitor

Jan. 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...